Gentis Inc.

Gentis, Inc.(Gentis) is a pharmaceutical company. It is principally engaged in the development of minimally synthetic, invasive, biomaterials-based products to treat the early-stage degeneration of the spine and for musculoskeletal. It offers DiscCell, an injectable, in-situ setting, radio-opaque, and non-hydrogel polymer material that replaces the diseased nucleus pulposus of the spinal disc. DiscCell is a novel biomaterial designed to restore the normal biomechanical function of a degenerated intervertebral disc by augmenting or replacing the gel like tissue at its center, the nucleus pulposus. Gentis is headquartered at Wayne in Pennsylvania, the US.

Street: 
400 E. Lancaster Ave
City: 
Wayne
Postcode: 
19087
Federal State : 
United States
WebSite: 
www.gentisinc.com
Fax: 
1-610-9710999

Company Index Score

Current Index Score Historical Index Score
  • Gentis Inc. currently scores 50 % in the index.
  • Gentis Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Gentis Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets